Filing Details
- Accession Number:
- 0001651844-17-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-31 13:31:57
- Reporting Period:
- 2017-05-26
- Filing Date:
- 2017-05-31
- Accepted Time:
- 2017-05-31 13:31:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1018735 | Nymox Pharmaceutical Corp | NYMX | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1651844 | George James Robinson | 10 East Lee Street Suite 2705 Baltimore MD 21202 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-05-26 | 4,500 | $3.78 | 49,550 | No | 4 | P | Indirect | Trust |
Common Stock | Acquisiton | 2017-05-26 | 3,800 | $3.75 | 2,961,350 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 4,500 | $3.76 | 2,965,850 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 120 | $3.77 | 2,965,970 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 2,110 | $3.79 | 2,968,080 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 3,970 | $3.80 | 2,972,050 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 7,800 | $3.81 | 2,979,850 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 6,200 | $3.82 | 2,986,050 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 10,000 | $3.83 | 2,996,050 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,500 | $3.87 | 2,997,550 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-30 | 3,500 | $3.82 | 3,001,050 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-30 | 2,200 | $3.85 | 3,003,250 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-30 | 1,800 | $3.86 | 3,005,050 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-30 | 2,500 | $3.90 | 3,007,550 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Trust |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,957,550 | Direct | |
Common Stock | 49,550 | Indirect | Trust |
Common Stock | 49,550 | Indirect | Trust |
Common Stock | 49,550 | Indirect | Trust |
Common Stock | 49,550 | Indirect | Trust |
Common Stock | 49,550 | Indirect | Trust |
Common Stock | 49,550 | Indirect | Trust |
Common Stock | 49,550 | Indirect | Trust |
Common Stock | 49,550 | Indirect | Trust |
Common Stock | 49,550 | Indirect | Trust |
Common Stock | 49,550 | Indirect | Trust |
Common Stock | 49,550 | Indirect | Trust |
Common Stock | 49,550 | Indirect | Trust |
Common Stock | 49,550 | Indirect | Trust |